Wells Fargo
CRVO icon

Wells Fargo’s CervoMed CRVO Stock Holding History

Wells Fargo’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-131
Closed -$823 – 7139
2025
Q2 		$823 Sell
131
-2,448
-95% -$20.9K ﹤0.01% 6331
2025
Q1 		$23.6K Buy
2,579
+56
+2% +$213 ﹤0.01% 5660
2024
Q4 		$5.9K Buy
2,523
+859
+52% +$8.35K ﹤0.01% 6033
2024
Q3 		$24.3K Sell
1,664
-66
-4% -$1.02K ﹤0.01% 5585
2024
Q2 		$29.6K Buy
1,730
+1,715
+11,433% +$37.5K ﹤0.01% 5469
2024
Q1 		$350 Buy
15
+1
+7% +$13 ﹤0.01% 6368
2023
Q4 		$107 Buy
14
+4
+40% +$35 ﹤0.01% 6749
2023
Q3 		$46 Hold
10
– – ﹤0.01% 6935
2023
Q2 		$50 Buy
10
+1
+11% +$6 ﹤0.01% 7052
2023
Q1 		$58 Sell
9
-75
-89% -$665 ﹤0.01% 7069
2022
Q4 		$637 Hold
84
– – ﹤0.01% 6316
2022
Q3 		$1K Hold
84
– – ﹤0.01% 6307
2022
Q2 		$1K Hold
84
– – ﹤0.01% 6487
2022
Q1 		$1K Sell
84
-11
-12% -$218 ﹤0.01% 6772
2021
Q4 		$2K Hold
95
– – ﹤0.01% 6873
2021
Q3 		$3K Sell
95
-1
-1% -$42 ﹤0.01% 6482
2021
Q2 		$5K Hold
96
– – ﹤0.01% 6331
2021
Q1 		$7K Buy
96
+19
+25% +$1.59K ﹤0.01% 6418
2020
Q4 		$4K Buy
77
+38
+97% +$2.23K ﹤0.01% 6174
2020
Q3 		$2K Buy
39
+3
+8% +$228 ﹤0.01% 6127
2020
Q2 		$2K Buy
36
+35
+3,500% +$2.13K ﹤0.01% 6088
2020
Q1 		$0 Sell
1
-66
-99% -$2K ﹤0.01% 6265
2019
Q4 		$2K Buy
+67
New +$4.09K ﹤0.01% 6162
2019
Q3 		– Sell
-1,998
Closed -$427K – 6404
2019
Q2 		$427K Buy
+1,998
New +$539K ﹤0.01% 4484

Other funds holding CRVO

AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Wells Fargo's CRVO Position: Q3 2025 in Review

Wells Fargo sold out of CervoMed (CRVO) in Q3 2025, closing a stake of 131 shares — an estimated $823 sold.

Wells Fargo first reported a position in CRVO in Q2 2019 and held it in 24 quarters. The position peaked at $427K in Q2 2019. 45 funds tracked by Wall St. Rank hold CRVO as of Q3 2025.

  • Wells Fargo reported no remaining CervoMed position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 131 CervoMed shares in Q3 2025, an estimated $823.
  • Wells Fargo first reported a position in CervoMed in Q2 2019 and held it in 24 quarters.
  • Wells Fargo's CervoMed position peaked at $427K in Q2 2019.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.